metastatic urothelial carcinoma

FDA Approves Keytruda/Padcev Combo in Advanced Urothelial Cancer
BioSpace
Tue, 04/4/23 - 12:35 pm
Merck
Seagen
Astellas
Keytruda
Padcev
metastatic urothelial carcinoma
FDA
BMS, Synairgen Regroup After Trials Miss Primary Endpoints
BioSpace
Mon, 05/16/22 - 10:36 am
Bristol Myers Squibb
NCT03036098
Opdivo-Yervoy
metastatic urothelial carcinoma
clinical trials
Synairgen